Addiction Toxicology Case Conference - January 2025

Dr. Maryann Amirshahi is a Professor of Emergency Medicine at Georgetown University School of Medicine and practices clinically at MedStar Washington Hospital Center, where she specializes in toxicology, addiction care, and emergency medicine. She holds a PharmD and medical degree, alongside an MPH focusing on environmental and occupational health, and a PhD in pharmacology and public health. Dr. Amirshahi is board-certified in emergency medicine, medical toxicology, addiction medicine, and clinical pharmacology, and is a registered pharmacist with over a decade of practice. Nationally recognized, she serves on the Board of Directors for the American College of Medical Toxicology and as co-medical director of the National Capital Poison Center. With nearly 200 peer-reviewed publications, her research spans medication safety, drug shortages, addiction treatment, and prescription drug misuse.

Maureen Boyle, PhD, is the Chief Quality and Science Officer at the American Society of Addiction Medicine (ASAM), where she oversees the development of clinical guidelines and tools to support the implementation of evidence-based practices in addiction treatment. She provides strategic leadership for the ASAM Criteria Suite of products, including ASAM CONTINUUM, the ASAM Level of Care Certification Program, and the ASAM Criteria textbook. With over 20 years of experience in research, public health, and policy, Dr. Boyle has held key leadership roles at the Substance Abuse and Mental Health Services Administration (SAMHSA) and the National Institute on Drug Abuse (NIDA). She earned her Ph.D. in Neuroscience from the Washington University School of Medicine, completed a postdoctoral fellowship at the Allen Institute for Brain Science, and is an alumna of the AAAS Science and Technology Policy Fellowship.

Dr. Emily Brunner is a board-certified family medicine physician and distinguished fellow in addiction medicine, specializing in trauma-informed, compassionate care for substance use disorders. She serves as Medical Director of Gateway Recovery and Recovering Hope and conducts trainings for the Hazelden Betty Ford Foundation. A recognized leader, she has held positions with the Minnesota Society of Addiction Medicine and currently serves on the national board of the American Society of Addiction Medicine. Dr. Brunner is a passionate advocate for expanding access to medications for opioid use disorder and improving care for patients with substance use disorders across the healthcare system. Named a Top Doctor in addiction medicine by Minnesota Magazine in 2020 and 2021, she also has a clinical interest in internet gaming and gambling disorders.

Dr. Alex Krotulski serves as an Associate Director at CFSRE working in the areas of forensic toxicology and forensic chemistry and is the Program Manager for NPS Discovery. Dr. Krotulski holds faculty appointment and serves as the Assistance Program Director for the Thomas Jefferson University Master of Science in Forensic Toxicology (MSFT) program and was recently appointed as an Associate Editor for the Journal of Analytical Toxicology. Dr. Krotulski received his Doctor of Philosophy degree in Analytical Chemistry from Temple University in 2019 following receipt of his Master of Science degree in Forensic Science from Arcadia University in 2015 and Bachelor of Science in Chemistry from Loyola University New Orleans in 2013.

Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). In 2023, he began a two-year term as Treasurer of ASAM, having previously served as Vice President on the Executive Council. Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.

Since 1986, Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.